1. Home
  2. KYMR vs JOE Comparison

KYMR vs JOE Comparison

Compare KYMR & JOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • JOE
  • Stock Information
  • Founded
  • KYMR 2015
  • JOE 1936
  • Country
  • KYMR United States
  • JOE United States
  • Employees
  • KYMR N/A
  • JOE N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • JOE Homebuilding
  • Sector
  • KYMR Health Care
  • JOE Real Estate
  • Exchange
  • KYMR Nasdaq
  • JOE Nasdaq
  • Market Cap
  • KYMR 3.1B
  • JOE 2.9B
  • IPO Year
  • KYMR 2020
  • JOE N/A
  • Fundamental
  • Price
  • KYMR $47.28
  • JOE $52.12
  • Analyst Decision
  • KYMR Strong Buy
  • JOE
  • Analyst Count
  • KYMR 15
  • JOE 0
  • Target Price
  • KYMR $58.53
  • JOE N/A
  • AVG Volume (30 Days)
  • KYMR 599.5K
  • JOE 214.8K
  • Earning Date
  • KYMR 10-30-2025
  • JOE 10-22-2025
  • Dividend Yield
  • KYMR N/A
  • JOE 1.08%
  • EPS Growth
  • KYMR N/A
  • JOE 16.57
  • EPS
  • KYMR N/A
  • JOE 1.42
  • Revenue
  • KYMR $44,711,000.00
  • JOE $426,624,000.00
  • Revenue This Year
  • KYMR $58.45
  • JOE N/A
  • Revenue Next Year
  • KYMR N/A
  • JOE N/A
  • P/E Ratio
  • KYMR N/A
  • JOE $36.56
  • Revenue Growth
  • KYMR N/A
  • JOE 10.09
  • 52 Week Low
  • KYMR $19.45
  • JOE $40.19
  • 52 Week High
  • KYMR $53.27
  • JOE $62.49
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 64.57
  • JOE 56.31
  • Support Level
  • KYMR $42.71
  • JOE $50.18
  • Resistance Level
  • KYMR $44.43
  • JOE $52.62
  • Average True Range (ATR)
  • KYMR 1.98
  • JOE 1.22
  • MACD
  • KYMR 0.60
  • JOE 0.18
  • Stochastic Oscillator
  • KYMR 91.51
  • JOE 80.94

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About JOE St. Joe Company (The)

The St. Joe Co is a real estate development, asset management, and operating company and it has three operating segments; the Residential segment plans and develops residential communities and sells homesites to homebuilders or retail consumers, the Hospitality segment that derives maximum revenue, features a private membership club, hotel operations, food and beverage operations, golf courses, beach clubs, retail outlets, gulf-front vacation rentals, management services, marinas, and other entertainment assets, and Commercial segment include leasing of commercial property, multi-family, senior living, self-storage, and other assets and it also oversees the planning, development, entitlement, management, and sale of commercial and rural land holdings.

Share on Social Networks: